Antibiotic exposure is associated with cutaneous adverse events in hairy cell leukemia patients treated with purine analogues

J Am Acad Dermatol. 2019 Jun;80(6):1762-1764. doi: 10.1016/j.jaad.2018.07.066. Epub 2018 Sep 8.

Authors

Rebecca F Wang¹, Daniel Li², Gina J Kuehn², Leslie A Andritsos³, Michael R Grever³, Benjamin H Kaffenberger²

Affiliations

¹ Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: Rebecca.Wang@osumc.edu.
² Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio.
³ Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio.

PMID: 30205132
DOI: 10.1016/j.jaad.2018.07.066

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Analysis of Variance
Anti-Bacterial Agents / adverse effects*
Anti-Bacterial Agents / therapeutic use
Antineoplastic Agents / administration & dosage
Cladribine / administration & dosage*
Cohort Studies
Drug Eruptions / epidemiology
Drug Eruptions / etiology*
Drug Interactions
Female
Follow-Up Studies
Humans
Incidence
Leukemia, Hairy Cell / drug therapy*
Leukemia, Hairy Cell / pathology
Male
Middle Aged
Multivariate Analysis
Pentostatin / administration & dosage*
Retrospective Studies
Risk Assessment

Substances

Anti-Bacterial Agents
Antineoplastic Agents
Pentostatin
Cladribine